HasanSyedJafriMDFAAP
Infectious Disease • San Jose, CAHealthcare Associated Infections, Transplant/Immunocompromised States, Clinical Pharmacology
Chief Medical Officer, Head of Clinical Development
Dr. Jafri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5941 Optical Ct
San Jose, CA 95138
Education & Training
University of Texas Southwestern Medical Center1996 - 1999
University of Texas Medical Branch HospitalsResidency, Pediatrics, 1993 - 1996
Centers for Disease Control and PreventionPost-Doctoral Fellowship, 1992 - 1993
Allama Iqbal Medical CollegeClass of 1990
Certifications & Licensure
TX State Medical License 1999 - 2026- National Board of Physicians and Surgeons Pediatrics
Clinical Trials
- MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States Start of enrollment: 2004 Nov 15
- Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) Start of enrollment: 2011 Oct 20
- MEDI-557 Adult Dosing Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 247 citationsA systematic review of risk factors associated with surgical site infections among surgical patients.Ellen E. Korol, Karissa Johnston, Nathalie Waser, Frangiscos Sifakis, Hasan S. Jafri
Plos One. 2013-12-18 - 316 citationsSevere Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyt...Timothy P. Welliver, Roberto P. Garofalo, Yashoda M. Hosakote, Karen H. Hintz, Luis F. Avendaño
The Journal of Infectious Diseases. 2007-04-15 - 52 citationsSingle-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.Susan M. Abdel-Rahman, David Benziger, Richard F. Jacobs, Hasan S. Jafri, Erica Fischer Hong
The Pediatric Infectious Disease Journal. 2008-04-01
Press Mentions
Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis PatientsMarch 13th, 2023- New Approaches to Treating Infections in Cystic Fibrosis Patients - AR 501 Phase 2 Trial UpdateJanuary 17th, 2023
- Phase 2a Trial of AR-501 for Lung Infections in CF Now Fully EnrolledDecember 1st, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
- American Society for MicrobiologyMember
- Pediatric Infectious Diseases SocietyMember
- European Society of Clinical Microbiology and Infectious DiseasesMember
- European Society for Paediatric Infectious DiseasesMember
Other Languages
- Hindi, Urdu, Punjabi
External Links
- LinkedInhttp://linkedin.com/in/hasan-jafri-b0b6836
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
